Evidence map›Paper›PMID 39104558›Full record

ArticleRSC advances2024

Ultra small gold nanoclusters supported on two-dimensional bismuth selenium nanosheets for synergistic photothermal and photodynamic tumor therapy.

Chenxi Li, Xueyang Fang, Qingdong Zeng, Li Zeng, Bin Zhang, Guohui Nie

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chenxi LiGraduate Collaborative Training Base of Shenzhen Second People's Hospital, Heng Yang Medical School, University of South China Hengyang Hunan 421001 China.
Xueyang FangShenzhen Key Laboratory of Nanozymes and Translational Cancer Research, Institute of Translational Medicine Department of Otolaryngology Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Health Science Center Shenzhen 518035 China binzhang@email.szu.edu.cn nieguohui@email.szu.edu.cn FANGXueyang0210@163.com.
Qingdong ZengGraduate Collaborative Training Base of Shenzhen Second People's Hospital, Heng Yang Medical School, University of South China Hengyang Hunan 421001 China.
Li ZengShenzhen Key Laboratory of Nanozymes and Translational Cancer Research, Institute of Translational Medicine Department of Otolaryngology Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Health Science Center Shenzhen 518035 China binzhang@email.szu.edu.cn nieguohui@email.szu.edu.cn FANGXueyang0210@163.com.
Bin ZhangShenzhen Key Laboratory of Nanozymes and Translational Cancer Research, Institute of Translational Medicine Department of Otolaryngology Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Health Science Center Shenzhen 518035 China binzhang@email.szu.edu.cn nieguohui@email.szu.edu.cn FANGXueyang0210@163.com.ORCID https://orcid.org/0000-0002-2112-2555
Guohui NieShenzhen Key Laboratory of Nanozymes and Translational Cancer Research, Institute of Translational Medicine Department of Otolaryngology Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Health Science Center Shenzhen 518035 China binzhang@email.szu.edu.cn nieguohui@email.szu.edu.cn FANGXueyang0210@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two-dimensional (2D) bismuth selenium (Bi

Identifiers

PMID39104558
PMCPMC11298975

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.